you cannot go on saying BP thinks elto isn't worth a dime. you simply cannot. you nor anyone else, not even GC, know what big pharma think elto is worth. there is no open bidding war, and no one will give an honest bid to a pre-rev, pre any clinical trial company. GC could easily be balking at offers many of us would be pulling our hair out saying dude take it! Fact is GC thought he could get through phase 2 nd uplist two years ago, which had he been successful, would have made any money we got from elto way higher. and after that we were under the toxic oppression facing imminent bankruptcy for 2 whole years!!! in a way, we still are. so why would any of them offer the company much at all. GC may be a guy who just doesn't want to get screwed, or us to get screwed, and in the process accidently/negligently screwed us all while holding valuable assets as is. the fact that we "stayed on the field" for two years should be proof that the powers that be was value in what we have. you saying elto isn't worth a dime because we haven't partnered it or sold it is like saying MANF is worthless for the same reason, and that's just silly.
all that aid, I have never been a cheerleader of elto and still don't see it's PD-LID potential if it screws up the Levadopa treatment.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links